# FDA Inspection 1287750 - 5N Plus Lubeck GmbH - April 27, 2023

Source: https://www.keypedia.com/records/fda_inspections/5n-plus-lubeck-gmbh/f21021aa-6763-4d58-8aeb-2abe351a8409
Source feed: FDA_Inspections

> FDA Inspection 1287750 for 5N Plus Lubeck GmbH on April 27, 2023. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1287750
- Company Name: 5N Plus Lubeck GmbH
- Inspection Date: 2023-04-27
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1074936 - 2018-11-09](https://www.keypedia.com/records/fda_inspections/5n-plus-lubeck-gmbh/f105813d-bea2-46e4-ba2c-94dae4d74211)
- [FDA Inspection 937613 - 2015-08-07](https://www.keypedia.com/records/fda_inspections/5n-plus-lubeck-gmbh/b1b65daf-892f-42a1-bc2d-42f37d7c7c3f)
- [FDA Inspection 792591 - 2012-07-26](https://www.keypedia.com/records/fda_inspections/5n-plus-lubeck-gmbh/5555d405-c3ee-4d05-bf35-9a537061f527)

Company: https://www.keypedia.com/companies/5n-plus-lubeck-gmbh/06c5eb0c-ca52-4a32-a391-adecd47035ba

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c